BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Valproic acid, rs4950928, EGFR, calcium channel activity, Allergy to pollen, Breast)
Bookmark Forward

QuickView for negative regulation of potassium ion transmembrane transporter activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Lymph nodes
  2. Jejunum
  3. Skeletal muscle
  4. Tongue main corpus
  5. Heart atrium
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Pyloric ulcer
  2. VATER association
  3. Vesicular stomatitis Indiana virus disease
  4. Alpha-1-antitrypsin deficiency
  5. Hypokalemic periodic paralysis
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. temsirolimus
  2. Butylhydroxybutylnitrosamine
  3. CGP 60474
  4. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  5. A 443654
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR192
  2. CAMK1
  3. ELN
  4. BLMH
  5. SCAF8
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
  2. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
  3. L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
  4. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for negative regulation of potassium ion transmembrane transporter activity
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.